A case for measuring both cellular and cell‐free mitochondrial DNA as a disease biomarker in human blood
Open Access
- 29 July 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (9) , 12278-12288
Abstract
Circulating mitochondrial DNA (mtDNA), widely studied as a disease biomarker, comprises of mtDNA located within mitochondria, indicative of mitochondrial function, and cell‐free (cf) mtDNA linked to inflammation. The purpose of this study was to determine the ranges of, and relationship between, cellular and cf mtDNA in human blood. Whole blood from 23 controls (HC) and 20 patients with diabetes was separated into peripheral blood mononuclear cells (PBMCs), plasma, and serum. Total DNA was isolated and mtDNA copy numbers were determined using absolute quantification. Cellular mtDNA content in PBMCs was higher than in peripheral blood and a surprisingly high level of cf mtDNA was present in serum and plasma of HC, with no direct relationship between cellular and cf mtDNA content within individuals. Diabetes patients had similar levels of cellular mtDNA compared to healthy participants but a significantly higher cf mtDNA content. Furthermore, only in patients with diabetes, we observed a correlation between whole blood and plasma mtDNA levels, indicating that the relationship between cellular and cf mtDNA content is affected by disease status. In conclusion, when evaluating mtDNA in human blood as a biomarker of mitochondrial dysfunction, it is important to measure both cellular and cf mtDNA.Keywords
Funding Information
- European Foundation for the Study of Diabetes
This publication has 53 references indexed in Scilit:
- Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and ValidationPLOS Medicine, 2013
- Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?Mitochondrion, 2013
- Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer diseaseAnnals of Neurology, 2013
- Mitochondrial DNA as a non-invasive biomarker: Accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution biasBiochemical and Biophysical Research Communications, 2011
- OXPHOS gene expression and control in mitochondrial disordersBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphomaBlood, 2008
- Platelet contamination causes large variation as well as overestimation of mitochondrial DNA content of peripheral blood mononuclear cellsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2008
- Mitochondrial DNA and the Mammalian Oocyte2007
- Mitochondrial DNA and RNA Increase in Peripheral Blood Mononuclear Cells from HIV‐1–Infected Patients Randomized to Receive Stavudine‐Containing or Stavudine‐Sparing Combination TherapyThe Journal of Infectious Diseases, 2005
- Tests for mitochondrial function and DNA: potentials and pitfallsCurrent Opinion in Infectious Diseases, 2003